CHD – Antiplatelets and Statins

Coronary Heart Disease – Antiplatelets and Statins

PREVIOUS                 NEXT 

Coronary Heart Disease – Antiplatelets and Statins 

Antiplatelets and CHD

A risk factor for CHD patients is the formation of blood clots. A type of medicine called antiplatelets have been shown to reduce the likelihood of a heart attack. These medicines achieve this by making the blood less thick which in turn makes it more unlikely that a clot will form. Here are four of the common medicines used for reducing risk of blood clot formation:

  1. Low dose aspirin
  2. Clopidogrel
  3. Prasugrel
  4. Ticagrelor

Statins and CHD

Statins are widely used in the UK based on evidence that they can help reduce low density lipoprotein (LDL) cholesterol levels in the blood. There are a number of statins on the market and four are listed here:

  1. Atorvastatin
  2. Simvastatin
  3. Rosuvastatin
  4. Pravastatin

The way statins work is that they help the liver mop up LDL cholesterol in the blood. They can do this by increasing the number of receptors in liver cells which specifically bind to the LDL. The reduction LDL cholesterol results in a reduced risk of a heart attack.

Going back to our work at Future genetics that centres on personalised medicine, we know that different people respond differently to a given treatment. Our goal is to provide clear information to doctors and patients so that the patient receives the right drug first time.